Urge your members of Congress to support continued medical research funding
ASH, the world's largest professional society concerned with the causes and treatments of blood disorders, regularly issues press releases highlighting clinical and research advances announced at the ASH annual meeting and published in Blood, as well as releases and statements on breaking policy news affecting the field of hematology.
Need to speak with an expert? Complete our Request An Expert form.
To be added to ASH's press release distribution list, contact Stephen Fitzmaurice at sfitzmaurice@hematology.org.
The American Society of Hematology will collaborate with the International Society on Thrombosis and Haemostasis, National Hemophilia Foundation, World Federation of Hemophilia, and the University of Kansas Medical Center to develop clinical practice guidelines on the diagnosis and management of von Willebrand Disease.
This World Sickle Cell Day, ASH hosted a webinar to raise global awareness about this devastating disease. Additionally, two new videos addressing the need for newborn screening and countering the prevailing myths about the disease in sub-Saharan Africa were unveiled.
Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.
View all
Urge your members of Congress to support continued medical research funding.
